colorectal, skin, and kidney cancers. The FDA approval covers a single 300 mg dose of Imjudo given alongside 1,500 mg Imfinzi, followed by Imfinzi every four weeks – known as the STRIDE (single ...
Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or returning to patients, according to a new study. Patients were given ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted and granted Priority Review in the US for the ...
Hosted on MSN2mon
AstraZeneca's Imfinzi Gets FDA Nod for Expanded Use in SCLCImfinzi is a key revenue driver for AZN’s oncology portfolio, having generated sales worth $3.46 billion in the first nine months of 2024, up 22% year over year at constant exchange rates ...
Hosted on MSN1mon
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLCPeople who are prone to accelerated aging may benefit from early screening for colorectal cancer (CRC ... post-irradiation durvalumab (Imfinzi) appeared to improve PFS in older, frail patients ...
AstraZeneca (AZ) has received two separate recommendations from the National Institute for Health and Care Excellence (NICE) for use of its lung cancer drugs Tagrisso (osimertinib) and Imfinzi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback